You are here
October is Breast Cancer Awareness Month
The cultural collective of breast cancer advocacy and awareness activities, and an abundance of education efforts, information and news coverage have made breast cancer a familiar disease.
Thanks to the significant strides made in early detection, research, treatment and patient empowerment over the past 30 years, there is much progress to celebrate. Indeed, the prognosis of early stage breast cancer has transformed as survival rates have steadily increased.
But there is more work to be done, including increasing the focus on late stage breast cancer.
View some of Pfizer's current efforts below:
Breast Cancer: A Story Half Told
In 2014, Pfizer and leaders in the breast cancer community embarked on a first-of-its-kind research initiative that highlighted the public's lack of knowledge about metastatic breast cancer (MBC)—the most advanced form of the disease, for which there is no cure. Breast Cancer: A Story Half Told sheds further light on MBC from the perspective of women living with the disease.
Breast Cancer Grants Programs
Pfizer is engaged in several grant initiatives to complement its robust clinical development program for breast cancer:
- Pfizer and the Union for International Cancer Control Award 20 Grants Totaling $760,000 to Address the Needs of Metastatic Breast Cancer Patients Worldwide
- Pfizer and the Avon Foundation for Women Award 23 Grants Totaling $1 Million in Funding to Support Patients Living With Metastatic Breast Cancer
Holley Kitchen - A Story Half Told: Behind the Scenes
Facing Breast Cancer in the Workplace
Khadijah Carter - A Story Half Told: Behind the Scenes
Mace Rothenberg on Unmet Needs in Metastatic Breast Cancer
